234 related articles for article (PubMed ID: 15149569)
21. Effect of mifepristone (RU486) on the pituitary response to gonadotrophin releasing hormone in women.
Kazem R; Messinis LE; Fowler P; Groome NP; Knight PG; Templeton AA
Hum Reprod; 1996 Dec; 11(12):2585-90. PubMed ID: 9021355
[TBL] [Abstract][Full Text] [Related]
22. Use of a single bolus of GnRH agonist triptorelin to trigger ovulation after GnRH antagonist ganirelix treatment in women undergoing ovarian stimulation for assisted reproduction, with special reference to the prevention of ovarian hyperstimulation syndrome: preliminary report: short communication.
Itskovitz-Eldor J; Kol S; Mannaerts B
Hum Reprod; 2000 Sep; 15(9):1965-8. PubMed ID: 10966996
[TBL] [Abstract][Full Text] [Related]
23. Influence of the luteinizing hormone-releasing hormone agonist, deslorelin, on patterns of estradiol-17 beta and luteinizing hormone secretion, ovarian follicular responses to superstimulation with follicle-stimulating hormone, and recovery and in vitro development of oocytes in heifer calves.
Maclellan LJ; Bergfeld EG; Earl CR; Fitzpatrick LA; Aspden WJ; Kinder JE; Walsh J; Trigg TE; D'Occhio MJ
Biol Reprod; 1997 Apr; 56(4):878-84. PubMed ID: 9096868
[TBL] [Abstract][Full Text] [Related]
24. The role of luteinizing hormone in human follicle development and oocyte fertility: evidence from in-vitro fertilization in a woman with long-standing hypogonadotrophic hypogonadism and using recombinant human follicle stimulating hormone.
Balasch J; Miró F; Burzaco I; Casamitjana R; Civico S; Ballescá JL; Puerto B; Vanrell JA
Hum Reprod; 1995 Jul; 10(7):1678-83. PubMed ID: 8582960
[TBL] [Abstract][Full Text] [Related]
25. Livebirth after orthotopic transplantation of cryopreserved ovarian tissue.
Donnez J; Dolmans MM; Demylle D; Jadoul P; Pirard C; Squifflet J; Martinez-Madrid B; van Langendonckt A
Lancet; 2004 Oct 16-22; 364(9443):1405-10. PubMed ID: 15488215
[TBL] [Abstract][Full Text] [Related]
26. The value of basal serum follicle stimulating hormone, luteinizing hormone and oestradiol concentrations following pituitary down-regulation in predicting ovarian response to stimulation with highly purified follicle stimulating hormone.
Develioglu OH; Cox B; Toner JP; Oehninger S; Muasher SJ
Hum Reprod; 1999 May; 14(5):1168-74. PubMed ID: 10325255
[TBL] [Abstract][Full Text] [Related]
27. [Correlation between serum inhibin B level after treatment with gonadotropin releasing hormone agonist and outcome of in vitro fertilization-embryo transfer].
Lin WQ; Yang HY; Lin JJ; Chen X; Ye BL
Zhonghua Fu Chan Ke Za Zhi; 2009 Apr; 44(4):260-2. PubMed ID: 19570462
[TBL] [Abstract][Full Text] [Related]
28. The serum follicle-stimulating hormone-to-luteinizing hormone ratio at the start of stimulation with gonadotropins after pituitary down-regulation is inversely correlated with a mature oocyte yield and can predict "low responders".
Ho JY; Guu HF; Yi YC; Chen MJ; Ho ES
Fertil Steril; 2005 Apr; 83(4):883-8. PubMed ID: 15820795
[TBL] [Abstract][Full Text] [Related]
29. Predicting successful induction of oocyte maturation after gonadotropin-releasing hormone agonist (GnRHa) trigger.
Kummer NE; Feinn RS; Griffin DW; Nulsen JC; Benadiva CA; Engmann LL
Hum Reprod; 2013 Jan; 28(1):152-9. PubMed ID: 23077235
[TBL] [Abstract][Full Text] [Related]
30. The effects of gonadotrophin-releasing hormone agonist on follicular development in patients with polycystic ovary syndrome in an in-vitro fertilization and embryo transfer programme.
Gersak K; Meden-Vrtovec H; Tomazevic T
Hum Reprod; 1994 Sep; 9(9):1596-9. PubMed ID: 7836506
[TBL] [Abstract][Full Text] [Related]
31. Unilateral follicular aspiration and in-vitro maturation before contralateral oocyte retrieval: a method to prevent ovarian hyperstimulation syndrome.
Schröder AK; Schöpper B; Al-Hasani S; Diedrich K; Ludwig M
Eur J Obstet Gynecol Reprod Biol; 2003 Oct; 110(2):186-9. PubMed ID: 12969581
[TBL] [Abstract][Full Text] [Related]
32. Determination of the efficiency of controlled ovarian hyperstimulation in the gonadotropin-releasing hormone agonist-suppression cycle using the initial follicle count during gonadotropin stimulation.
Huang FJ; Chang SY; Tsai MY; Kung FT; Wu JF; Chang HW
J Assist Reprod Genet; 2001 Feb; 18(2):91-6. PubMed ID: 11285987
[TBL] [Abstract][Full Text] [Related]
33. Gonadotropin-releasing hormone antagonist versus agonist administration in women undergoing controlled ovarian hyperstimulation: cycle performance and in vitro steroidogenesis of granulosa-lutein cells.
Minaretzis D; Alper MM; Oskowitz SP; Lobel SM; Mortola JF; Pavlou SN
Am J Obstet Gynecol; 1995 May; 172(5):1518-25. PubMed ID: 7755066
[TBL] [Abstract][Full Text] [Related]
34. The first Australian experience of heterotopic grafting of cryopreserved ovarian tissue: evidence of establishment of normal ovarian function.
Stern CJ; Toledo MG; Hale LG; Gook DA; Edgar DH
Aust N Z J Obstet Gynaecol; 2011 Jun; 51(3):268-75. PubMed ID: 21631450
[TBL] [Abstract][Full Text] [Related]
35. Anti-Müllerian hormone: correlation of early follicular, ovulatory and midluteal levels with ovarian response and cycle outcome in intracytoplasmic sperm injection patients.
Elgindy EA; El-Haieg DO; El-Sebaey A
Fertil Steril; 2008 Jun; 89(6):1670-6. PubMed ID: 17658520
[TBL] [Abstract][Full Text] [Related]
36. Functional studies of subcutaneous ovarian transplants in non-human primates: steroidogenesis, endometrial development, ovulation, menstrual patterns and gamete morphology.
Schnorr J; Oehninger S; Toner J; Hsiu J; Lanzendorf S; Williams R; Hodgen G
Hum Reprod; 2002 Mar; 17(3):612-9. PubMed ID: 11870112
[TBL] [Abstract][Full Text] [Related]
37. Hormonal and histologic findings in human cryopreserved ovarian autografts.
Dittrich R; Mueller A; Maltaris T; Hoffmann I; Magener A; Oppelt PG; Beckmann MW
Fertil Steril; 2009 Apr; 91(4 Suppl):1503-6. PubMed ID: 18930206
[TBL] [Abstract][Full Text] [Related]
38. [Response of cryopreserved ovarian tissue after autologous implantation in mouse stimulated with gonadotrophin].
Yu X; Deng XH; Chao L; Yu HL; Liu WJ
Zhonghua Fu Chan Ke Za Zhi; 2008 Mar; 43(3):213-7. PubMed ID: 18788573
[TBL] [Abstract][Full Text] [Related]
39. Dynamics of the development of multiple follicles during ovarian stimulation for in vitro fertilization using recombinant follicle-stimulating hormone (Puregon) and various doses of the gonadotropin-releasing hormone antagonist ganirelix (Orgalutran/Antagon).
de Jong D; Macklon NS; Eijkemans MJ; Mannaerts BM; Coelingh Bennink HJ; Fauser BC;
Fertil Steril; 2001 Apr; 75(4):688-93. PubMed ID: 11287020
[TBL] [Abstract][Full Text] [Related]
40. The effect of ovarian arterial infusion of transforming growth factor alpha on ovarian follicle populations and ovarian hormone secretion in ewes with an autotransplanted ovary.
Campbell BK; Gordon BM; Scaramuzzi RJ
J Endocrinol; 1994 Oct; 143(1):13-24. PubMed ID: 7964312
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
